Ligand Pharmaceuticals
LGND
LGND
261 hedge funds and large institutions have $2.47B invested in Ligand Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 79 increasing their positions, 115 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
261
Holders Change
–
Holders Change %
0%
% of All Funds
5.36%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.1%
New
39
Increased
79
Reduced
115
Closed
35
Calls
$39.1M
Puts
$139M
Net Calls
-$100M
Net Calls Change
-$67.3M
Top Buyers
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$51.9M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$35.3M |
| 3 |
State Street
Boston,
Massachusetts
|
-$27.1M |
| 4 |
GCM
Geneva Capital Management
Milwaukee,
Wisconsin
|
-$17.8M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$14.6M |